Baidu
map
BMC COMPLEMENT MED 润色咨询

BMC Complementary Medicine and Therapies

出版年份:2020 年文章数:734 投稿命中率: 开通期刊会员,数据随心看

出版周期:C 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2024-11-12 ms50505068863585589 来自浙江省

    审稿速度:12.0
    经验分享:这杂志简直慢的离谱。现在还没消息
    Submission history:
    Submission received
    Submission status Date
    Submission received
    30 Jan 2024
    Technical check
    Submission status Date
    Submission is under technical check
    30 Jan 2024
    Amendment requested
    23 May 2024
    Amendment received
    25 May 2024
    Amendment requested
    27 May 2024
    Amendment received
    28 May 2024
    Amendment requested
    07 Jun 2024
    Amendment received
    08 Jun 2024
    Submission passed technical check
    14 Jun 2024
    Editorial assignment
    Submission status Date
    Ready for editorial assignment
    14 Jun 2024
    With editor
    Submission status Date
    Editor assigned
    14 Jun 2024
    Revision requested
    09 Jul 2024
    Revision received
    17 Jul 2024
    Submission passed technical check
    17 Jul 2024
    Revision requested
    28 Aug 2024
    Revision received
    29 Aug 2024
    Submission passed technical check
    29 Aug 2024

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2024-05-24 ms9000001670056033 来自河北省

    复方因为有动物成分被拒?

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2023-11-06 147350dfm22暂无昵称 来自广东省

    偏重的研究方向:药学
    经验分享:10月16号提交技术审查,到现在都还没通过。。。。

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2023-03-02 ms1000000305223838 来自河北省

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:中医
    经验分享:这个期刊if到底是多少

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2021-06-15 12171fa9m59暂无昵称

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:干细胞;中药小分子
    经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF
    拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!

    5

    展开5条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2024-04-06 ms9000001026547573 来自香港

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:补充医学;临床
    经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。
    第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。
    觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2021-11-03 ms3000000150745947

    好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2023-11-20 ms5000001496653792 来自天津

    审稿速度:2.0
    经验分享:发

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2023-08-16 ms8000001033052510 来自湖南省

    有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2236528, encodeId=66872236528fe, content=审稿速度:12.0<br>经验分享:这杂志简直慢的离谱。现在还没消息<br>Submission history:<br>Submission received<br>Submission status Date<br>Submission received<br>30 Jan 2024<br>Technical check<br>Submission status Date<br>Submission is under technical check<br>30 Jan 2024<br>Amendment requested<br>23 May 2024<br>Amendment received<br>25 May 2024<br>Amendment requested<br>27 May 2024<br>Amendment received<br>28 May 2024<br>Amendment requested<br>07 Jun 2024<br>Amendment received<br>08 Jun 2024<br>Submission passed technical check<br>14 Jun 2024<br>Editorial assignment<br>Submission status Date<br>Ready for editorial assignment<br>14 Jun 2024<br>With editor<br>Submission status Date<br>Editor assigned<br>14 Jun 2024<br>Revision requested<br>09 Jul 2024<br>Revision received<br>17 Jul 2024<br>Submission passed technical check<br>17 Jul 2024<br>Revision requested<br>28 Aug 2024<br>Revision received<br>29 Aug 2024<br>Submission passed technical check<br>29 Aug 2024<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=ms50505068863585589, createdTime=Tue Nov 12 16:01:03 CST 2024, time=2024-11-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2206493, encodeId=d5b32206493bd, content=复方因为有动物成分被拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdb58501218, createdName=ms9000001670056033, createdTime=Fri May 24 22:56:59 CST 2024, time=2024-05-24, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2167079, encodeId=1903216e0796c, content=偏重的研究方向:药学<br>经验分享:10月16号提交技术审查,到现在都还没通过。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7bd05198828, createdName=147350dfm22暂无昵称, createdTime=Mon Nov 06 19:51:40 CST 2023, time=2023-11-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117300, encodeId=46b1211e3002c, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中医<br>经验分享:这个期刊if到底是多少, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26486561809, createdName=ms1000000305223838, createdTime=Thu Mar 02 23:16:01 CST 2023, time=2023-03-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=973879, encodeId=3b6b9e38795f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:干细胞;中药小分子<br>经验分享:2020年12月22日投出,1月中旬才送外审,4月才回第一个审稿人的意见,5月拒稿。历时半年WTF<br>拒稿理由是,我的wb图是裁剪过的,他们需要完整没裁剪的!!!!印度编辑的要求!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d1322255226, createdName=12171fa9m59暂无昵称, createdTime=Tue Jun 15 21:33:29 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197135, encodeId=7d2c219e135db, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:补充医学;临床<br>经验分享:第一篇是2022年3月投出去的,期间返修了2次,2023年1月接收的,审稿意见特别详细,但是内容很好,大概十几页,reply letter最后大概有接近30页,比文章还长。但是确实感觉到reviewer认真在给我看了。<br>第二篇是2023年11月投的,返修1次,2024年2月接收的,审稿意见也给的很好,总之就是慢认真的,我们也认真的回复了,很快就接收了。<br>觉得杂志主编的态度很好,认真找审稿人,也努力在推进了,质量把控的也很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d169190550, createdName=ms9000001026547573, createdTime=Sat Apr 06 12:57:31 CST 2024, time=2024-04-06, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1066633, encodeId=b7541066633fc, content=好奇怪,为什么明明审稿人意见已经回来,然后就又变回邀请编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b0e05530779, createdName=ms3000000150745947, createdTime=Wed Nov 03 16:42:15 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2169816, encodeId=9a1721698161a, content=审稿速度:2.0<br>经验分享:发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45585705840, createdName=ms5000001496653792, createdTime=Mon Nov 20 20:07:39 CST 2023, time=2023-11-20, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2153091, encodeId=2ca8215309123, content=有大佬知道这个杂志,审稿意见回来一个多月了,编辑部一直没有消息,是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:56:03 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2153090, encodeId=5e66215309035, content=Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bea08338785, createdName=ms8000001033052510, createdTime=Wed Aug 16 20:48:51 CST 2023, time=2023-08-16, status=1, ipAttribution=湖南省)]
    2023-08-16 ms8000001033052510 来自湖南省

    Reviewer reports received / Ready for editor’s decision 审稿意见回来一个多月了,编辑部一直没有通知,有大佬有这种经历嘛

    0

共62条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map